[Congressional Record Volume 171, Number 132 (Thursday, July 31, 2025)]
[Senate]
[Page S5102]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 3330. Mr. SCHIFF submitted an amendment intended to be proposed by 
him to the bill S. 2296, to authorize appropriations for fiscal year 
2026 for military activities of the Department of Defense, for military 
construction, and for defense activities of the Department of Energy, 
to prescribe military personnel strengths for such fiscal year, and for 
other purposes; which was ordered to lie on the table; as follows:

       At the appropriate place in title II, insert the following:

     SEC. 2__. CODIFICATION OF DEFENSE MATERIAL PRIORITY AREAS FOR 
                   THE DISTRIBUTED BIOINDUSTRIAL MANUFACTURING 
                   PROGRAM.

       (a) Amendment.--Paragraph (1) of section 215(c) of the 
     James M. Inhofe National Defense Authorization Act for Fiscal 
     Year 2023 (Public Law 117-263; 10 U.S.C. 4841 note) is 
     amended to read as follows:
       ``(1) research on the use of bioindustrial manufacturing to 
     create materials such as--
       ``(A) polymers;
       ``(B) coatings;
       ``(C) resins;
       ``(D) commodity chemicals;
       ``(E) food and food ingredients, including nutritionally 
     complete proteins produced through bioindustrial 
     manufacturing;
       ``(F) fuel and energy feedstocks;
       ``(G) fitness related biomaterials, including performance 
     nutrition and resilience products;
       ``(H) fabrication materials such as high performance 
     fibers, polymers, and resins;
       ``(I) firepower materials, including precursors for 
     energetics and munitions;
       ``(J) pharmaceutical biologics and associated precursor 
     materials; and
       ``(K) other materials with fragile supply chains;''.
       (b) Rule of Construction.--Nothing in paragraph (1) of such 
     section, as amended by subsection (a), shall be construed to 
     limit the authority of the Secretary of Defense to support 
     additional bioindustrial manufacturing activities under 
     section 215 of such Act or as otherwise authorized by any 
     other provision of law.
                                 ______